Position in HALO
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$35,223
-$1,792 QoQ
Shares Held
545
-0.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in HALO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Centerpoint Advisors, LLC holds $78,047 across 7 Biotechnology names. HALO ranks #2 (45.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
87 | $38,848 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
This page
|
545 | $35,223 | |
| 3 | PHVS |
Pharvaris N.V.
|
100 | $2,825 | |
| 4 | GERN |
Geron Corp
|
300 | $447 | |
| 5 | NMRA |
Neumora Therapeutics, Inc.
|
220 | $429 | |
| 6 | YARW |
Yarrow Bioscience, Inc.
|
350 | $209 | |
| 7 | RNA |
Atrium Therapeutics, Inc.
|
5 | $66 |
All Filings in HALO
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $35,223 | 545 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $37,015 | 550 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $40,337 | 550 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $28,611 | 550 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $35,095 | 550 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $26,295 | 550 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $31,482 | 550 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $28,798 | 550 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $22,374 | 550 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $20,328 | 550 | Shares | Sole | 2024-01-16 | |
| 2023-09-30 | $26,740 | 700 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $25,249 | 700 | Shares | Sole | 2023-07-17 | |
| 2023-03-31 | $26,733 | 700 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $39,830 | 700 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $41,517 | 1,050 | Shares | Sole | 2022-10-13 | |
| 2022-06-30 | $46,200 | 1,050 | Shares | Sole | 2022-07-18 | |
| 2022-03-31 | $41,874 | 1,050 | Shares | Sole | 2022-04-27 | |
| 2021-12-31 | $44,231 | 1,100 | Shares | Sole | 2022-01-14 | |
| 2021-09-30 | $44,748 | 1,100 | Shares | Sole | 2021-10-25 | |
| 2021-06-30 | $49,951 | 1,100 | Shares | Sole | 2021-07-26 | |
| 2021-03-31 | $45,859 | 1,100 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $46,981 | 1,100 | Shares | Sole | 2021-01-22 | |
| 2020-09-30 | $28,908 | 1,100 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $29,491 | 1,100 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $19,789 | 1,100 | Shares | Sole | 2020-04-23 | |
| No filing history on record for this holder in this stock. | ||||||